
Robert S. Cabral
Examiner (ID: 17715, Phone: (571)270-3769 , Office: P/1618 )
| Most Active Art Unit | 1618 |
| Art Unit(s) | 1614, 1618 |
| Total Applications | 983 |
| Issued Applications | 563 |
| Pending Applications | 85 |
| Abandoned Applications | 347 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 16204981
[patent_doc_number] => 20200237971
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-30
[patent_title] => DELIVERY OF HYDROPHOBIC ACTIVE AGENT PARTICLES
[patent_app_type] => utility
[patent_app_number] => 16/847272
[patent_app_country] => US
[patent_app_date] => 2020-04-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21146
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 54
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16847272
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/847272 | Delivery of hydrophobic active agent particles | Apr 12, 2020 | Issued |
Array
(
[id] => 17088703
[patent_doc_number] => 11116873
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-09-14
[patent_title] => Solid substrates for promoting cell and tissue growth
[patent_app_type] => utility
[patent_app_number] => 16/837232
[patent_app_country] => US
[patent_app_date] => 2020-04-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 62
[patent_no_of_words] => 29094
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 119
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16837232
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/837232 | Solid substrates for promoting cell and tissue growth | Mar 31, 2020 | Issued |
Array
(
[id] => 17609665
[patent_doc_number] => 20220151944
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-19
[patent_title] => FLUOROURACIL-CONTAINING FORMULATIONS
[patent_app_type] => utility
[patent_app_number] => 17/598595
[patent_app_country] => US
[patent_app_date] => 2020-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13249
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17598595
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/598595 | FLUOROURACIL-CONTAINING FORMULATIONS | Mar 29, 2020 | Pending |
Array
(
[id] => 17627210
[patent_doc_number] => 20220162225
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-26
[patent_title] => PH-DEPENDENT COMPOSITION MATTERS USEFUL FOR STUDY AND DIAGNOSIS OF ALZHEIMER'S DISEASE
[patent_app_type] => utility
[patent_app_number] => 17/598509
[patent_app_country] => US
[patent_app_date] => 2020-03-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10987
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17598509
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/598509 | pH-dependent composition matters useful for study and diagnosis of alzheimer's disease | Mar 26, 2020 | Issued |
Array
(
[id] => 19165869
[patent_doc_number] => 11981757
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-05-14
[patent_title] => Injection molded medical devices made from a high molecular weight polyethylene
[patent_app_type] => utility
[patent_app_number] => 16/826475
[patent_app_country] => US
[patent_app_date] => 2020-03-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5511
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 162
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16826475
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/826475 | Injection molded medical devices made from a high molecular weight polyethylene | Mar 22, 2020 | Issued |
Array
(
[id] => 16459544
[patent_doc_number] => 10842872
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-11-24
[patent_title] => Fluorescein and benoxinate compositions
[patent_app_type] => utility
[patent_app_number] => 16/820593
[patent_app_country] => US
[patent_app_date] => 2020-03-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 29
[patent_no_of_words] => 60590
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 82
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16820593
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/820593 | Fluorescein and benoxinate compositions | Mar 15, 2020 | Issued |
Array
(
[id] => 16296311
[patent_doc_number] => 20200282034
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-09-10
[patent_title] => LIGHT-MEDIATED TREATMENTS OF METASTATIC CANCERS
[patent_app_type] => utility
[patent_app_number] => 16/810548
[patent_app_country] => US
[patent_app_date] => 2020-03-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9578
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 184
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16810548
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/810548 | LIGHT-MEDIATED TREATMENTS OF METASTATIC CANCERS | Mar 4, 2020 | Abandoned |
Array
(
[id] => 17609645
[patent_doc_number] => 20220151924
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-19
[patent_title] => MODULAR METAL-ORGANIC POLYHEDRA SUPERASSEMBLY COMPOSITIONS
[patent_app_type] => utility
[patent_app_number] => 17/434363
[patent_app_country] => US
[patent_app_date] => 2020-02-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10879
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17434363
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/434363 | Modular metal-organic polyhedra superassembly compositions | Feb 26, 2020 | Issued |
Array
(
[id] => 16267442
[patent_doc_number] => 20200268929
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-08-27
[patent_title] => SETTABLE SILICON NITRIDE CEMENTS
[patent_app_type] => utility
[patent_app_number] => 16/799248
[patent_app_country] => US
[patent_app_date] => 2020-02-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8518
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16799248
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/799248 | SETTABLE SILICON NITRIDE CEMENTS | Feb 23, 2020 | Abandoned |
Array
(
[id] => 16270100
[patent_doc_number] => 20200271587
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-08-27
[patent_title] => VISIBLE LIGHT-ACTIVATED DYES AND METHODS OF USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/798992
[patent_app_country] => US
[patent_app_date] => 2020-02-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19314
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16798992
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/798992 | Visible light-activated dyes and methods of use thereof | Feb 23, 2020 | Issued |
Array
(
[id] => 20824976
[patent_doc_number] => 12678518
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-07-14
[patent_title] => Theranostic probe and its use for targeting and/or labeling the EGFR kinase and/or the cells expressing EGFR or its family members
[patent_app_type] => utility
[patent_app_number] => 17/756689
[patent_app_country] => US
[patent_app_date] => 2020-02-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 10790
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 182
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17756689
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/756689 | Theranostic probe and its use for targeting and/or labeling the EGFR kinase and/or the cells expressing EGFR or its family members | Feb 20, 2020 | Issued |
Array
(
[id] => 16052889
[patent_doc_number] => 20200188299
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-06-18
[patent_title] => METHOD FOR TREATING A SWALLOWING DISORDER
[patent_app_type] => utility
[patent_app_number] => 16/796476
[patent_app_country] => US
[patent_app_date] => 2020-02-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6897
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 100
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16796476
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/796476 | Method for treating a swallowing disorder | Feb 19, 2020 | Issued |
Array
(
[id] => 17975409
[patent_doc_number] => 11492256
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-11-08
[patent_title] => Compositions of hypochlorous acid and methods of manufacture thereof
[patent_app_type] => utility
[patent_app_number] => 16/795000
[patent_app_country] => US
[patent_app_date] => 2020-02-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 12
[patent_no_of_words] => 7452
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16795000
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/795000 | Compositions of hypochlorous acid and methods of manufacture thereof | Feb 18, 2020 | Issued |
Array
(
[id] => 16053123
[patent_doc_number] => 20200188416
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-06-18
[patent_title] => METHODS OF TREATING ADVANCED PROSTATE CANCER
[patent_app_type] => utility
[patent_app_number] => 16/787589
[patent_app_country] => US
[patent_app_date] => 2020-02-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16425
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16787589
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/787589 | Methods of treating advanced prostate cancer | Feb 10, 2020 | Issued |
Array
(
[id] => 19209620
[patent_doc_number] => 11998658
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-06-04
[patent_title] => Injectable porous hydrogels
[patent_app_type] => utility
[patent_app_number] => 16/786312
[patent_app_country] => US
[patent_app_date] => 2020-02-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 121
[patent_no_of_words] => 16295
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 78
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16786312
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/786312 | Injectable porous hydrogels | Feb 9, 2020 | Issued |
Array
(
[id] => 16222659
[patent_doc_number] => 20200247775
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-08-06
[patent_title] => PRODRUG AND PROFLUORESCENT COMPOUNDS FOR SELECTIVE MITOCHONDRIAL IMAGING AND THERAPEUTIC TARGETING
[patent_app_type] => utility
[patent_app_number] => 16/784202
[patent_app_country] => US
[patent_app_date] => 2020-02-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10624
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -3
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16784202
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/784202 | Prodrug and profluorescent compounds for selective mitochondrial imaging and therapeutic targeting | Feb 5, 2020 | Issued |
Array
(
[id] => 18319698
[patent_doc_number] => 20230117826
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-20
[patent_title] => COMPOUNDS AND COMPOSITIONS FOR RETINAL INJURY DETECTION AND METHODS OF USING SAME
[patent_app_type] => utility
[patent_app_number] => 17/759912
[patent_app_country] => US
[patent_app_date] => 2020-02-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14626
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 130
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17759912
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/759912 | COMPOUNDS AND COMPOSITIONS FOR RETINAL INJURY DETECTION AND METHODS OF USING SAME | Feb 4, 2020 | Abandoned |
Array
(
[id] => 15928195
[patent_doc_number] => 20200155731
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-05-21
[patent_title] => DEVICE AND METHOD FOR PROMOTING RAPID STRUT COVERAGE AND VASCULAR ENDOTHELIAL COVERAGE
[patent_app_type] => utility
[patent_app_number] => 16/773911
[patent_app_country] => US
[patent_app_date] => 2020-01-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10202
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 114
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16773911
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/773911 | DEVICE AND METHOD FOR PROMOTING RAPID STRUT COVERAGE AND VASCULAR ENDOTHELIAL COVERAGE | Jan 26, 2020 | Abandoned |
Array
(
[id] => 17609649
[patent_doc_number] => 20220151928
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-19
[patent_title] => HIGH DENSITY LIPOPROTEIN MIMETIC NANOPARTICLES USING LIPID CONJUGATED CORE SCAFFOLDS
[patent_app_type] => utility
[patent_app_number] => 17/425401
[patent_app_country] => US
[patent_app_date] => 2020-01-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16388
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -46
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17425401
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/425401 | High density lipoprotein mimetic nanoparticles using lipid conjugated core scaffolds | Jan 23, 2020 | Issued |
Array
(
[id] => 19550209
[patent_doc_number] => 12133901
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-11-05
[patent_title] => PSMA ligand targeted compounds and uses thereof
[patent_app_type] => utility
[patent_app_number] => 17/424084
[patent_app_country] => US
[patent_app_date] => 2020-01-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 13
[patent_no_of_words] => 12343
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 64
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17424084
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/424084 | PSMA ligand targeted compounds and uses thereof | Jan 20, 2020 | Issued |